Project 2 Airway Potential Hydrogen (pH) in Asthma

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

November 1, 2018

Primary Completion Date

July 16, 2025

Study Completion Date

July 16, 2025

Conditions
Cystic FibrosisAsthmaSevere Persistent AsthmaHealthy
Interventions
DRUG

Glycine Buffer

Subjects will be asked to perform an Inhaled Glycine Buffer followed by a series of Pulmonary Function Tests (PFTs) and then a research bronchoscopy will happen at visit 3.

Trial Locations (2)

44106

University Hospitals Cleveland Medical Center - Asthma Research Center, Cleveland

46202

Indiana University School of Medicine, Indianapolis

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

collaborator

University Hospitals Cleveland Medical Center

OTHER

lead

Case Western Reserve University

OTHER

NCT03617718 - Project 2 Airway Potential Hydrogen (pH) in Asthma | Biotech Hunter | Biotech Hunter